Three FDA Advisors Resign over Agency’s Approval of Shoddy New Alzheimer’s Drug
In November 2020, an independent panel slammed Aduhelm, a new Alzheimer’s drug just approved by the FDA. When asked if there was supportive evidence for the use of this drug, zero out of the seven pan
Original source: https://rumble.com/v1xhnfa-three-fda-advisors-resign-over-agencys-approval-of-shoddy-new-alzheimers-dr.html
